217 related articles for article (PubMed ID: 37373186)
1. Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data.
Zhan YP; Chen BS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373186
[TBL] [Abstract][Full Text] [Related]
2. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
3. Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications.
Su PW; Chen BS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430344
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
5. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications.
Chang S; Chen JY; Chuang YJ; Chen BS
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269
[TBL] [Abstract][Full Text] [Related]
6. Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach.
Hsu BW; Chen BS
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371627
[TBL] [Abstract][Full Text] [Related]
7. Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method.
Yeh SJ; Yeh TY; Chen BS
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743172
[TBL] [Abstract][Full Text] [Related]
8. Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms.
Yeh SJ; Hsu BJ; Chen BS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802957
[TBL] [Abstract][Full Text] [Related]
9. Multiple-Molecule Drug Design Based on Systems Biology Approaches and Deep Neural Network to Mitigate Human Skin Aging.
Yeh SJ; Lin JF; Chen BS
Molecules; 2021 May; 26(11):. PubMed ID: 34073305
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer.
Yeh SJ; Chen SW; Chen BS
Front Genet; 2020; 11():117. PubMed ID: 32211020
[TBL] [Abstract][Full Text] [Related]
11. Systems Medicine Design based on Systems Biology Approaches and Deep Neural Network for Gastric Cancer.
Yeh SJ; Chen BS
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):3019-3031. PubMed ID: 34232888
[TBL] [Abstract][Full Text] [Related]
12. Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method.
Chang S; Wang LH; Chen BS
Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32878239
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Role of Obesity in Prostate Cancer and Identifying Biomarkers for Drug Discovery: Systems Biology and Deep Learning Approaches.
Yeh SJ; Chung YC; Chen BS
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164166
[TBL] [Abstract][Full Text] [Related]
14. Investigating Common Pathogenic Mechanisms between
Yeh SJ; Yeh CC; Lan CY; Chen BS
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30769958
[No Abstract] [Full Text] [Related]
15. Investigation mechanisms between normal, developing and regenerating livers for regenerative liver drug design.
Wong SW; Yeh SJ; Li CW; Wang LH; Chen BS
Regen Med; 2019 May; 14(5):359-387. PubMed ID: 31204905
[No Abstract] [Full Text] [Related]
16. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer.
Yeh SJ; Lin CY; Li CW; Chen BS
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126066
[TBL] [Abstract][Full Text] [Related]
17. Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification.
Yeh SJ; Chang CA; Li CW; Wang LH; Chen BS
Oncotarget; 2019 Jun; 10(38):3760-3806. PubMed ID: 31217907
[TBL] [Abstract][Full Text] [Related]
18. Investigating Pathogenetic Mechanisms of Alzheimer's Disease by Systems Biology Approaches for Drug Discovery.
Yeh SJ; Chung MH; Chen BS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681938
[TBL] [Abstract][Full Text] [Related]
19. Network Pharmacology-Based Analysis on the Mechanism of Action of Ephedrae Herba-Cinnamomi Ramulus Couplet Medicines in the Treatment for Psoriasis.
Guo S; Zhou JY; Tan C; Shi L; Shi Y; Shi J
Med Sci Monit; 2021 Jan; 27():e927421. PubMed ID: 33513128
[TBL] [Abstract][Full Text] [Related]
20. Identification of key pathways and genes in psoriasis via gene microarray analysis.
Chen W; Xie K; Liu X; Chen H
Mol Med Rep; 2016 Mar; 13(3):2327-37. PubMed ID: 26781069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
